X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Daily MedNews - 05/03/2025 11:15

Stem Cell Therapy Repairs Irreversible Cornea Damage

WEDNESDAY, March 5, 2025 -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows.The cornea -- the clear outermost layer of the eye -- can become irreversibly damaged if...

Articles similaires

Study Finds: In-Womb Stem Cell Treatment Safe for Spina Bifida

medindia.net - 28/Feb 11:00

Lancet Phase 1 study finds in-womb stem cell therapy feasible and safe in spina bifida, supporting expansion to a larger clinical trial.

Playing Holi? Protect Your Eyes from Color Irritation

medindia.net - 10:43

Holi color powders and chemical dyes can irritate the cornea and conjunctiva. Experts recommend protective eyewear and prompt eye rinsing to prevent...

Playing Holi? Protect Your Eyes from Color Irritation

medindia.net - 10:43

Holi color powders and chemical dyes can irritate the cornea and conjunctiva. Experts recommend protective eyewear and prompt eye rinsing to prevent...

Sorry! Image not available at this time

Frailty can be eased with an infusion of stem cells from young people

wn.com - 28/Feb 10:35

Frailty can typically only be lessened through lifestyle changes, but a stem cell therapy seems to target the underlying causes of the condition,...

Sorry! Image not available at this time

Frailty can be eased with an infusion of stem cells from young people

wn.com - 28/Feb 10:35

Frailty can typically only be lessened through lifestyle changes, but a stem cell therapy seems to target the underlying causes of the condition,...

Giving stem cells in utero to babies with spina bifida boosts quality of life, trial finds

theguardian.com - 26/Feb 23:30

Experimental therapy of applying stem cells during surgery could be ‘major milestone’ in treatment of birth defects

Optimized costimulatory domains boost tumor killing in CAR NK cells

news.medical.net - 21/Feb 02:47

Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new...

Sorry! Image not available at this time

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment

wn.com - 20/Feb 03:25

Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for...

Sorry! Image not available at this time

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment

wn.com - 20/Feb 03:25

Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for...

Sorry! Image not available at this time

FDA Approves Hernexeos, the First Targeted Therapy for Adults with HER2-Mutant Advanced NSCLC as an Initial Treatment Option

drugs.com - 26/Feb 04:02

Ridgefield, Conn. and Ingelheim, Germany, February, 26, 2026 -- The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s...